11 reports

You can easily book an appointment with one online.

  • Transplantation
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • ORGAN TRANSPLANTATIONS PERFORMED IN THE UK, 2013 VS. 2015

In January 2016, bioMérieux commercialized its Film Array Meningitis/ Encephalitis (ME) Panel used for the identification of CNS infectious agents.

  • Genome Sequencing
  • Transplantation
  • North America
  • United States
  • Market Size

The prominent features of this report are - ##.

  • Infectious Disease
  • Medical Biotechnology
  • Therapy
  • Transplantation
  • Chimerix, Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Product Initiative

## Phase I ## ## Preclinical ## ## Discovery ## ## Total ## ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR KIDNEY TRANSPLANT REJECTION, H## 2018 Stage of Develop

  • Health Services
  • Therapy
  • Transplantation
  • United States
  • Product Initiative
  • MONOCLONAL ANTIBODY TO INHIBIT IL-2 FOR ENCEPHALOPATHY, GRAFT VERSUS HOST DISEASE AND TYPE 1 DIABETES - DRUG PROFILE

Fourteen patients developed ## grade ## toxicities, including lymphopenia in ## patients, hyperglycemia in ##, ALT elevation in ##, thrombocytopenia in ##, lung infection in ##, AST elevation in ##, neutropenia in ##, urinary tract infection in ##, colitis in ##, febrile ne

  • Healthcare
  • Medical Biotechnology
  • Transplantation
  • United States
  • Product Initiative

Kidney Transplant Rejection - Overview Kidney Transplant Rejection - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR KIDNEY TRANSPLANT REJECTION, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR KIDNEY TRANSPLANT REJECTION, H## 2018 Pre-Registration ## ## Ph

  • Healthcare
  • Therapy
  • Transplantation
  • United States
  • Product Initiative
  • MONOCLONAL ANTIBODY TO INHIBIT IL-2 FOR ENCEPHALOPATHY, GRAFT VERSUS HOST DISEASE AND TYPE 1 DIABETES - DRUG PROFILE
  • CELLULAR IMMUNOTHERAPY TO TARGET HLA-A2 FOR GRAFT VERSUS HOST DISEASE (GVHD) - DRUG PROFILE

Fourteen patients developed ## grade ## toxicities, including lymphopenia in ## patients, hyperglycemia in ##, ALT elevation in ##, thrombocytopenia in ##, lung infection in ##, AST elevation in ##, neutropenia in ##, urinary tract infection in ##, colitis in ##, febrile ne

  • Cell Therapy
  • Specialty Hospital
  • Therapy
  • Transplantation
  • Pluristem Therapeutics Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG

Fourteen patients developed ## grade ## toxicities, including lymphopenia in ## patients, hyperglycemia in ##, ALT elevation in ##, thrombocytopenia in ##, lung infection in ##, AST elevation in ##, neutropenia in ##, urinary tract infection in ##, colitis in ##, febrile ne

  • Healthcare
  • Medical Biotechnology
  • Transplantation
  • United States
  • Product Initiative

In the experimental autoimmune encephalitis mouse model of MS, short term treatments with CGEN-## resulted in a long term dramatic improvement of disease symptoms.

  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • Transplantation
  • Pluristem Therapeutics Inc.